Scroll to the top

{{ subpage.title }}

Omicron & the undoing of China's COVID strategy
Omicron and the Undoing of China’s COVID Strategy | GZERO World with Ian Bremmer

Omicron & the undoing of China's COVID strategy

Omicron is here. The bad news is that it's more contagious. The good news is that mRNA vaccines work against death and hospitalization. COVID may soon become endemic in some parts of the world.

Not in China, where Xi Jinping's zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low.

Read moreShow less

Podcast: The problem with China’s Zero COVID strategy

Transcript

Listen: Xi Jinping's zero-COVID approach faces its toughest test to date with omicron. Why? Because China lacks mRNA jabs, and so few Chinese people have gotten COVID that overall protection is very low. A wave of lockdowns could disrupt the world's second-largest economy — just a month out from the Beijing Winter Olympics.

That could spell disaster for Beijing, Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, tells Ian Bremmer on the GZERO World podcast. If things get really bad, though, Huang believes China will pivot to living with the virus, especially as the cost of keeping zero COVID in the age of omicron becomes too high.

Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform, to receive new episodes as soon as they're published.
Graphic by Ari Winkleman

The Graphic Truth: The unequal road to herd immunity

When will we return to a pre-pandemic normal by achieving COVID-19 herd immunity? Well, that depends where you live. While a host of wealthy nations that stockpiled vaccines and have already started rolling them out are planning for a post-COVID recovery in the near-term, the bulk of middle-income states will have to wait many months until the vaccine is rolled out to large swaths of the population. Most developing nations, meanwhile, as well as countries that will only get drugs through the global COVAX facility, may still be living with the coronavirus for three more years, according to predictions by The Economist Intelligence Unit. We compare when the pandemic is likely to end in different groups of countries, based on their access to vaccines and rollout plans.

COVID vaccine development could be damaged by politics, says former US Surgeon General
COVID Vaccine Development Could Be Damaged by Politics, Says Former US Surgeon General | GZERO World

COVID vaccine development could be damaged by politics, says former US Surgeon General

"When we already have enough challenges with people understanding the science behind vaccines, we cannot afford to allow the development and approval of a vaccine to be further politicized," Dr. Vivek Murthy told Ian Bremmer on GZERO World. The former US Surgeon General expressed concerns that politics could hurt the process of development and distribution while shaking public confidence. He also discusses the current state of development for a COVID-19 vaccine, and possible scenarios for its efficacy once available.

Ask an epidemiologist: Harvard's Marc Lipsitch answers your COVID questions
Have Burning Questions about the Latest in the Pandemic? Ask an Epidemiologist | GZERO World

Ask an epidemiologist: Harvard's Marc Lipsitch answers your COVID questions

Do masks really protect us? Are children less vulnerable to COVID-19? And why do scientists hope you avoid indoor bars? This week, GZERO World is taking all of our burning questions about the latest in the pandemic to a Harvard epidemiologist. Marc Lipsitch is a Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and the Director of the Center for Communicable Disease Dynamics. So, he knows his stuff!

Ian Bremmer: The United States isn't Sweden
Ian Bremmer: The United States Isn't Sweden | Lessons We Don't Have | Response to NYT's Tom Friedman

Ian Bremmer: The United States isn't Sweden

I don't usually respond directly to individual op-eds but when it's Tom Friedman in The New York Times, and you're talking about how we respond to global coronavirus, well, it seems like it's a good time to weigh in. The op-ed in question: "Is Sweden Doing It Right?" And asking essentially, on the back of that, therefore, should we be Sweden, the United States? Is that the direction that we want to go in? And by the way, do we know what Sweden actually did? And this is really one that you need to take a red pen to.

Read moreShow less

Subscribe to our free newsletter, GZERO Daily

Latest